

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle maturation (GO:0016188) | 6.51416511 |
| 2 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 5.44276009 |
| 3 | regulation of synapse structural plasticity (GO:0051823) | 5.22923010 |
| 4 | locomotory exploration behavior (GO:0035641) | 5.02107372 |
| 5 | sodium ion export (GO:0071436) | 4.75615743 |
| 6 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.67854301 |
| 7 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.55690984 |
| 8 | synaptic vesicle exocytosis (GO:0016079) | 4.55335232 |
| 9 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.42496596 |
| 10 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.42156740 |
| 11 | ribosomal small subunit biogenesis (GO:0042274) | 4.39978728 |
| 12 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 4.31727813 |
| 13 | glutamate secretion (GO:0014047) | 4.31376397 |
| 14 | cell communication by electrical coupling (GO:0010644) | 4.28229333 |
| 15 | activation of protein kinase A activity (GO:0034199) | 4.25794561 |
| 16 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.13518002 |
| 17 | UV protection (GO:0009650) | 4.13465849 |
| 18 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 4.10369011 |
| 19 | DNA deamination (GO:0045006) | 4.08326708 |
| 20 | cellular potassium ion homeostasis (GO:0030007) | 3.94369317 |
| 21 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.94267369 |
| 22 | neuromuscular process controlling posture (GO:0050884) | 3.93548765 |
| 23 | regulation of translational termination (GO:0006449) | 3.92306908 |
| 24 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 3.82966249 |
| 25 | deoxyribose phosphate biosynthetic process (GO:0046385) | 3.82966249 |
| 26 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.82838926 |
| 27 | regulation of synaptic vesicle transport (GO:1902803) | 3.78306389 |
| 28 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.76115516 |
| 29 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.75913507 |
| 30 | negative regulation of microtubule polymerization (GO:0031115) | 3.69336914 |
| 31 | vocalization behavior (GO:0071625) | 3.68398652 |
| 32 | layer formation in cerebral cortex (GO:0021819) | 3.68258417 |
| 33 | protein localization to endosome (GO:0036010) | 3.63887622 |
| 34 | negative regulation of cell size (GO:0045792) | 3.60034730 |
| 35 | prostaglandin biosynthetic process (GO:0001516) | 3.58667943 |
| 36 | prostanoid biosynthetic process (GO:0046457) | 3.58667943 |
| 37 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.58309580 |
| 38 | exploration behavior (GO:0035640) | 3.54365813 |
| 39 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.53882167 |
| 40 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.52919693 |
| 41 | neurotransmitter secretion (GO:0007269) | 3.51460182 |
| 42 | neuronal action potential propagation (GO:0019227) | 3.49187113 |
| 43 | nuclear envelope reassembly (GO:0031468) | 3.45891534 |
| 44 | mitotic nuclear envelope reassembly (GO:0007084) | 3.45891534 |
| 45 | neuromuscular process controlling balance (GO:0050885) | 3.40839420 |
| 46 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.39611104 |
| 47 | GDP-mannose metabolic process (GO:0019673) | 3.38938232 |
| 48 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.37705045 |
| 49 | positive regulation of synapse maturation (GO:0090129) | 3.37282002 |
| 50 | regulation of early endosome to late endosome transport (GO:2000641) | 3.36515331 |
| 51 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling | 3.33356531 |
| 52 | cerebellar Purkinje cell layer development (GO:0021680) | 3.32108486 |
| 53 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 3.27201770 |
| 54 | pinocytosis (GO:0006907) | 3.24984107 |
| 55 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.21481519 |
| 56 | potassium ion export (GO:0071435) | 3.19878051 |
| 57 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.18541318 |
| 58 | protein localization to synapse (GO:0035418) | 3.17701948 |
| 59 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.13357184 |
| 60 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.12172756 |
| 61 | response to pheromone (GO:0019236) | 3.10677781 |
| 62 | protein retention in ER lumen (GO:0006621) | 3.09672819 |
| 63 | stress fiber assembly (GO:0043149) | 3.02657848 |
| 64 | proline biosynthetic process (GO:0006561) | 3.02601730 |
| 65 | plasma membrane repair (GO:0001778) | 3.02567460 |
| 66 | response to gravity (GO:0009629) | 3.01980655 |
| 67 | positive regulation of fibroblast migration (GO:0010763) | 3.00946106 |
| 68 | activation of MAPKKK activity (GO:0000185) | 3.00834955 |
| 69 | peptidyl-arginine omega-N-methylation (GO:0035247) | 3.00063025 |
| 70 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.99428912 |
| 71 | viral transcription (GO:0019083) | 2.99280838 |
| 72 | barbed-end actin filament capping (GO:0051016) | 2.98891694 |
| 73 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.98769182 |
| 74 | signal complex assembly (GO:0007172) | 2.95693732 |
| 75 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001241) | 2.95320163 |
| 76 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.94151094 |
| 77 | regulation of ARF GTPase activity (GO:0032312) | 2.93774291 |
| 78 | regulation of glucocorticoid metabolic process (GO:0031943) | 2.93146340 |
| 79 | cell communication involved in cardiac conduction (GO:0086065) | 2.92610344 |
| 80 | pyrimidine nucleotide catabolic process (GO:0006244) | 2.90564285 |
| 81 | potassium ion import (GO:0010107) | 2.88659143 |
| 82 | dopamine receptor signaling pathway (GO:0007212) | 2.87540339 |
| 83 | modulation by virus of host process (GO:0019054) | 2.87247096 |
| 84 | cellular sodium ion homeostasis (GO:0006883) | 2.87212422 |
| 85 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.86707401 |
| 86 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.85850448 |
| 87 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.84054819 |
| 88 | protein targeting to plasma membrane (GO:0072661) | 2.83820873 |
| 89 | mitotic G1 DNA damage checkpoint (GO:0031571) | 2.82740911 |
| 90 | focal adhesion assembly (GO:0048041) | 2.82121019 |
| 91 | cell-substrate adherens junction assembly (GO:0007045) | 2.82121019 |
| 92 | regulation of ARF protein signal transduction (GO:0032012) | 2.81886027 |
| 93 | negative regulation of B cell apoptotic process (GO:0002903) | 2.81061739 |
| 94 | positive regulation of protein dephosphorylation (GO:0035307) | 2.79589863 |
| 95 | regulation of defense response to virus by virus (GO:0050690) | 2.79292872 |
| 96 | regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway | 2.78551308 |
| 97 | membrane repolarization (GO:0086009) | 2.78238137 |
| 98 | activation of Rac GTPase activity (GO:0032863) | 2.78145698 |
| 99 | axon cargo transport (GO:0008088) | 2.77406391 |
| 100 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.75568495 |
| 101 | cAMP biosynthetic process (GO:0006171) | 2.74841918 |
| 102 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.74102059 |
| 103 | positive regulation of lamellipodium assembly (GO:0010592) | 2.73808239 |
| 104 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.72868586 |
| 105 | modulation by symbiont of host cellular process (GO:0044068) | 2.71581403 |
| 106 | protein maturation by protein folding (GO:0022417) | 2.70408181 |
| 107 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.70406010 |
| 108 | growth hormone secretion (GO:0030252) | 2.69903308 |
| 109 | regulation of synaptic plasticity (GO:0048167) | 2.69858691 |
| 110 | positive regulation of axon extension (GO:0045773) | 2.68937440 |
| 111 | apoptotic process involved in morphogenesis (GO:0060561) | 2.68707597 |
| 112 | positive regulation of membrane potential (GO:0045838) | 2.68393322 |
| 113 | deoxyribonucleoside diphosphate metabolic process (GO:0009186) | 2.67178105 |
| 114 | glycine transport (GO:0015816) | 2.66455548 |
| 115 | deoxyribonucleotide catabolic process (GO:0009264) | 2.65959641 |
| 116 | mature B cell differentiation involved in immune response (GO:0002313) | 2.65673946 |
| 117 | adherens junction assembly (GO:0034333) | 2.65020569 |
| 118 | adenine nucleotide transport (GO:0051503) | 2.64776802 |
| 119 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 2.64422717 |
| 120 | mitochondrial fragmentation involved in apoptotic process (GO:0043653) | 2.63778697 |
| 121 | translational termination (GO:0006415) | 2.62651694 |
| 122 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.62548214 |
| 123 | dendritic spine morphogenesis (GO:0060997) | 2.61842871 |
| 124 | membrane depolarization during action potential (GO:0086010) | 2.61840733 |
| 125 | regulation of sodium ion transmembrane transporter activity (GO:2000649) | 2.61776572 |
| 126 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.61071211 |
| 127 | potassium ion homeostasis (GO:0055075) | 2.60583524 |
| 128 | nucleotide salvage (GO:0043173) | 2.59469953 |
| 129 | translational elongation (GO:0006414) | 2.59406253 |
| 130 | regulation of membrane repolarization (GO:0060306) | 2.59339468 |
| 131 | adenosine receptor signaling pathway (GO:0001973) | 2.59106071 |
| 132 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.56942142 |
| 133 | proline transport (GO:0015824) | 2.56884577 |
| 134 | protein heterotrimerization (GO:0070208) | 2.56148012 |
| 135 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.55793182 |
| 136 | positive regulation of protein sumoylation (GO:0033235) | 2.55717216 |
| 137 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.55716974 |
| 138 | nucleoside diphosphate biosynthetic process (GO:0009133) | 2.55343315 |
| 139 | adhesion of symbiont to host (GO:0044406) | 2.55098447 |
| 140 | angiogenesis involved in wound healing (GO:0060055) | 2.55060099 |
| 141 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.54447587 |
| 142 | regulation of necrotic cell death (GO:0010939) | 2.53880134 |
| 143 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.53563231 |
| 144 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.53563231 |
| 145 | adhesion of symbiont to host cell (GO:0044650) | 2.53465495 |
| 146 | virion attachment to host cell (GO:0019062) | 2.53465495 |
| 147 | protein insertion into membrane (GO:0051205) | 2.53216545 |
| 148 | positive regulation of dendritic spine development (GO:0060999) | 2.51290215 |
| 149 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.51121771 |
| 150 | histone arginine methylation (GO:0034969) | 2.50187525 |
| 151 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.49914367 |
| 152 | establishment of nucleus localization (GO:0040023) | 2.49606002 |
| 153 | deoxyribose phosphate catabolic process (GO:0046386) | 2.47968656 |
| 154 | prepulse inhibition (GO:0060134) | 2.46168377 |
| 155 | glucose catabolic process (GO:0006007) | 2.44975753 |
| 156 | Golgi transport vesicle coating (GO:0048200) | 2.44753101 |
| 157 | COPI coating of Golgi vesicle (GO:0048205) | 2.44753101 |
| 158 | type B pancreatic cell proliferation (GO:0044342) | 2.44087984 |
| 159 | UTP biosynthetic process (GO:0006228) | 2.44059970 |
| 160 | platelet aggregation (GO:0070527) | 2.43827700 |
| 161 | deoxyribonucleotide biosynthetic process (GO:0009263) | 2.43379610 |
| 162 | response to auditory stimulus (GO:0010996) | 2.42654356 |
| 163 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.42641848 |
| 164 | regulation of ion transmembrane transporter activity (GO:0032412) | 2.42247763 |
| 165 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.42244530 |
| 166 | pentose-phosphate shunt (GO:0006098) | 2.41974472 |
| 167 | lipopolysaccharide biosynthetic process (GO:0009103) | 2.41383709 |
| 168 | pyrimidine nucleoside triphosphate metabolic process (GO:0009147) | 2.41114499 |
| 169 | cell-substrate junction assembly (GO:0007044) | 2.39831310 |
| 170 | modulation by virus of host morphology or physiology (GO:0019048) | 2.38249157 |
| 171 | maturation of SSU-rRNA (GO:0030490) | 2.37468178 |
| 172 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.37306166 |
| 173 | positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling | 2.36579894 |
| 174 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway | 2.36579894 |
| 175 | peptidyl-proline hydroxylation (GO:0019511) | 2.36086444 |
| 176 | regulation of mitochondrial membrane potential (GO:0051881) | 2.35237548 |
| 177 | viral life cycle (GO:0019058) | 2.35164643 |
| 178 | 2-deoxyribonucleotide metabolic process (GO:0009394) | 2.35106002 |
| 179 | negative regulation of necrotic cell death (GO:0060547) | 2.33646778 |
| 180 | cell migration involved in heart development (GO:0060973) | 2.31658825 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * LXR_22292898_ChIP-Seq_THP-1_Human | 2.86599569 |
| 2 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.85584746 |
| 3 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.80954923 |
| 4 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.70513677 |
| 5 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.65129570 |
| 6 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.56141826 |
| 7 | MYC_22102868_ChIP-Seq_BL_Human | 2.54775003 |
| 8 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 2.39538628 |
| 9 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.35073892 |
| 10 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.28282860 |
| 11 | * KDM2B_26808549_Chip-Seq_DND41_Human | 2.25999528 |
| 12 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.25180744 |
| 13 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.21343394 |
| 14 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.20322714 |
| 15 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.09350872 |
| 16 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 2.08417799 |
| 17 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 2.04068231 |
| 18 | KDM2B_26808549_Chip-Seq_K562_Human | 1.99306795 |
| 19 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.97755271 |
| 20 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.96623725 |
| 21 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.96409101 |
| 22 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.95501628 |
| 23 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.88084373 |
| 24 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.86615322 |
| 25 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.81874255 |
| 26 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.81421081 |
| 27 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.80453966 |
| 28 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.77939957 |
| 29 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.77102232 |
| 30 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.74144040 |
| 31 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.72655795 |
| 32 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.72612646 |
| 33 | P68_20966046_ChIP-Seq_HELA_Human | 1.72145808 |
| 34 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.71351412 |
| 35 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.67690737 |
| 36 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.63675476 |
| 37 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.63052186 |
| 38 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.61604387 |
| 39 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.59894277 |
| 40 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.58520409 |
| 41 | * MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.58061431 |
| 42 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.56191433 |
| 43 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.55640981 |
| 44 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.55127093 |
| 45 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.55119991 |
| 46 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.54391329 |
| 47 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.54159186 |
| 48 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.51544428 |
| 49 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.50190143 |
| 50 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.47873113 |
| 51 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.47280513 |
| 52 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.46612707 |
| 53 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.46324360 |
| 54 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.45338502 |
| 55 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.45192315 |
| 56 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.44451256 |
| 57 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.41473784 |
| 58 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.38546816 |
| 59 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.37412702 |
| 60 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.35384183 |
| 61 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.35302422 |
| 62 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.35124865 |
| 63 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.34103239 |
| 64 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.31977850 |
| 65 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.31808332 |
| 66 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.31563836 |
| 67 | * TP53_22127205_ChIP-Seq_IMR90_Human | 1.30487455 |
| 68 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.30244697 |
| 69 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.29191312 |
| 70 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 1.28569609 |
| 71 | * CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.27121751 |
| 72 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.26349962 |
| 73 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.25865162 |
| 74 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.25618728 |
| 75 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.25307751 |
| 76 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.24953542 |
| 77 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.23935656 |
| 78 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.23271936 |
| 79 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.23271936 |
| 80 | * FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.22954170 |
| 81 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.22496254 |
| 82 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.22183460 |
| 83 | SPI1_23127762_ChIP-Seq_K562_Human | 1.21976329 |
| 84 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.21632106 |
| 85 | ATF3_27146783_Chip-Seq_COLON_Human | 1.20558561 |
| 86 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.20070148 |
| 87 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.20013088 |
| 88 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.19728068 |
| 89 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.19490561 |
| 90 | * MAF_26560356_Chip-Seq_TH1_Human | 1.18883363 |
| 91 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.18781776 |
| 92 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.18064862 |
| 93 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.17614698 |
| 94 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.17011422 |
| 95 | UTX_26944678_Chip-Seq_JUKART_Human | 1.16584156 |
| 96 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.16448700 |
| 97 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.16052876 |
| 98 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.15906546 |
| 99 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.15243100 |
| 100 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.14153975 |
| 101 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.14070967 |
| 102 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.14007366 |
| 103 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.13738465 |
| 104 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.12717573 |
| 105 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.12418231 |
| 106 | * CTCF_21964334_Chip-Seq_Bcells_Human | 1.12309034 |
| 107 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.11557363 |
| 108 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.11499693 |
| 109 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.11466542 |
| 110 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11244103 |
| 111 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.10408484 |
| 112 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.10166149 |
| 113 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.09868311 |
| 114 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.09633229 |
| 115 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.09429666 |
| 116 | * SA1_27219007_Chip-Seq_Bcells_Human | 1.09183295 |
| 117 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.08463711 |
| 118 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.07840732 |
| 119 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.07615732 |
| 120 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.07596363 |
| 121 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.07581575 |
| 122 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.07242036 |
| 123 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.07194022 |
| 124 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.06589835 |
| 125 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.06576712 |
| 126 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.05806967 |
| 127 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.05535996 |
| 128 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.04444512 |
| 129 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.04298017 |
| 130 | * MAF_26560356_Chip-Seq_TH2_Human | 1.03967531 |
| 131 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.03162516 |
| 132 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.02552412 |
| 133 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.99928607 |
| 134 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 0.98725764 |
| 135 | * CTCF_20526341_ChIP-Seq_ESCs_Human | 0.98500600 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.48531616 |
| 2 | MP0008438_abnormal_cutaneous_collagen | 3.44884702 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 3.34505941 |
| 4 | MP0002909_abnormal_adrenal_gland | 2.95688719 |
| 5 | MP0005451_abnormal_body_composition | 2.93090508 |
| 6 | MP0004858_abnormal_nervous_system | 2.88338704 |
| 7 | MP0000751_myopathy | 2.75871190 |
| 8 | MP0002877_abnormal_melanocyte_morpholog | 2.62296616 |
| 9 | MP0004270_analgesia | 2.54759478 |
| 10 | MP0002063_abnormal_learning/memory/cond | 2.47397981 |
| 11 | MP0003329_amyloid_beta_deposits | 2.46649311 |
| 12 | MP0008961_abnormal_basal_metabolism | 2.39265007 |
| 13 | MP0002822_catalepsy | 2.38631806 |
| 14 | MP0005167_abnormal_blood-brain_barrier | 2.18789326 |
| 15 | MP0000013_abnormal_adipose_tissue | 2.12935972 |
| 16 | MP0002064_seizures | 2.11968151 |
| 17 | MP0001968_abnormal_touch/_nociception | 2.09725677 |
| 18 | MP0009745_abnormal_behavioral_response | 2.04374621 |
| 19 | MP0003075_altered_response_to | 1.96074734 |
| 20 | MP0002089_abnormal_postnatal_growth/wei | 1.94422293 |
| 21 | MP0003191_abnormal_cellular_cholesterol | 1.91636323 |
| 22 | MP0003880_abnormal_central_pattern | 1.88384567 |
| 23 | MP0009379_abnormal_foot_pigmentation | 1.86731388 |
| 24 | MP0004811_abnormal_neuron_physiology | 1.85552765 |
| 25 | MP0003705_abnormal_hypodermis_morpholog | 1.80734855 |
| 26 | MP0001542_abnormal_bone_strength | 1.80442275 |
| 27 | MP0008569_lethality_at_weaning | 1.74842373 |
| 28 | MP0003566_abnormal_cell_adhesion | 1.74827660 |
| 29 | MP0004130_abnormal_muscle_cell | 1.72769718 |
| 30 | MP0010368_abnormal_lymphatic_system | 1.70485506 |
| 31 | MP0002733_abnormal_thermal_nociception | 1.69532674 |
| 32 | MP0002736_abnormal_nociception_after | 1.66572276 |
| 33 | MP0003172_abnormal_lysosome_physiology | 1.64974981 |
| 34 | MP0004185_abnormal_adipocyte_glucose | 1.63630846 |
| 35 | MP0003283_abnormal_digestive_organ | 1.63067222 |
| 36 | MP0003436_decreased_susceptibility_to | 1.62216968 |
| 37 | MP0009046_muscle_twitch | 1.61027854 |
| 38 | MP0003279_aneurysm | 1.60036521 |
| 39 | MP0010030_abnormal_orbit_morphology | 1.58205485 |
| 40 | MP0000678_abnormal_parathyroid_gland | 1.57897589 |
| 41 | MP0001348_abnormal_lacrimal_gland | 1.56706377 |
| 42 | MP0002272_abnormal_nervous_system | 1.55870602 |
| 43 | MP0000681_abnormal_thyroid_gland | 1.54138354 |
| 44 | MP0001970_abnormal_pain_threshold | 1.53337788 |
| 45 | MP0002572_abnormal_emotion/affect_behav | 1.53069638 |
| 46 | MP0005464_abnormal_platelet_physiology | 1.51326805 |
| 47 | MP0000749_muscle_degeneration | 1.50502235 |
| 48 | MP0004145_abnormal_muscle_electrophysio | 1.48639343 |
| 49 | MP0004084_abnormal_cardiac_muscle | 1.46794720 |
| 50 | MP0003879_abnormal_hair_cell | 1.46257415 |
| 51 | MP0002269_muscular_atrophy | 1.45974833 |
| 52 | MP0002734_abnormal_mechanical_nocicepti | 1.44410878 |
| 53 | MP0002735_abnormal_chemical_nociception | 1.44121860 |
| 54 | MP0000747_muscle_weakness | 1.42815092 |
| 55 | MP0005423_abnormal_somatic_nervous | 1.40743440 |
| 56 | MP0000858_altered_metastatic_potential | 1.40720796 |
| 57 | MP0005257_abnormal_intraocular_pressure | 1.38609797 |
| 58 | MP0003303_peritoneal_inflammation | 1.37814113 |
| 59 | MP0003137_abnormal_impulse_conducting | 1.37697397 |
| 60 | MP0004215_abnormal_myocardial_fiber | 1.36349009 |
| 61 | MP0009384_cardiac_valve_regurgitation | 1.35766210 |
| 62 | MP0003633_abnormal_nervous_system | 1.34329261 |
| 63 | MP0008260_abnormal_autophagy | 1.34297324 |
| 64 | MP0004272_abnormal_basement_membrane | 1.34100812 |
| 65 | MP0000750_abnormal_muscle_regeneration | 1.31448965 |
| 66 | MP0004233_abnormal_muscle_weight | 1.30973363 |
| 67 | MP0000343_altered_response_to | 1.30550414 |
| 68 | MP0005330_cardiomyopathy | 1.29332296 |
| 69 | MP0005501_abnormal_skin_physiology | 1.28546118 |
| 70 | MP0000955_abnormal_spinal_cord | 1.25094472 |
| 71 | MP0000733_abnormal_muscle_development | 1.24939067 |
| 72 | MP0003091_abnormal_cell_migration | 1.21992735 |
| 73 | MP0009333_abnormal_splenocyte_physiolog | 1.20909944 |
| 74 | MP0005375_adipose_tissue_phenotype | 1.18651791 |
| 75 | MP0004087_abnormal_muscle_fiber | 1.16852792 |
| 76 | MP0000604_amyloidosis | 1.16639152 |
| 77 | MP0005023_abnormal_wound_healing | 1.13247860 |
| 78 | MP0002184_abnormal_innervation | 1.12161933 |
| 79 | MP0001958_emphysema | 1.11558250 |
| 80 | MP0004036_abnormal_muscle_relaxation | 1.11340864 |
| 81 | MP0000759_abnormal_skeletal_muscle | 1.10283489 |
| 82 | MP0003123_paternal_imprinting | 1.07980706 |
| 83 | MP0009780_abnormal_chondrocyte_physiolo | 1.07470171 |
| 84 | MP0005076_abnormal_cell_differentiation | 1.06809257 |
| 85 | MP0008874_decreased_physiological_sensi | 1.05786006 |
| 86 | MP0005508_abnormal_skeleton_morphology | 1.05495164 |
| 87 | MP0005058_abnormal_lysosome_morphology | 1.03976595 |
| 88 | MP0001486_abnormal_startle_reflex | 1.03822102 |
| 89 | MP0001984_abnormal_olfaction | 1.01572371 |
| 90 | MP0002060_abnormal_skin_morphology | 1.01511725 |
| 91 | MP0003122_maternal_imprinting | 1.01262546 |
| 92 | MP0004510_myositis | 1.01060558 |
| 93 | MP0000767_abnormal_smooth_muscle | 1.00701233 |
| 94 | MP0002067_abnormal_sensory_capabilities | 1.00555903 |
| 95 | MP0005390_skeleton_phenotype | 1.00301791 |
| 96 | MP0005503_abnormal_tendon_morphology | 0.99992403 |
| 97 | MP0004085_abnormal_heartbeat | 0.99791572 |
| 98 | MP0009278_abnormal_bone_marrow | 0.99574579 |
| 99 | MP0002066_abnormal_motor_capabilities/c | 0.99452984 |
| 100 | MP0002249_abnormal_larynx_morphology | 0.97695093 |
| 101 | MP0005623_abnormal_meninges_morphology | 0.95986340 |
| 102 | MP0003763_abnormal_thymus_physiology | 0.95762004 |
| 103 | MP0004947_skin_inflammation | 0.95582039 |
| 104 | MP0001501_abnormal_sleep_pattern | 0.95529071 |
| 105 | MP0001905_abnormal_dopamine_level | 0.94064191 |
| 106 | MP0002106_abnormal_muscle_physiology | 0.93865321 |
| 107 | MP0001502_abnormal_circadian_rhythm | 0.92817575 |
| 108 | MP0002557_abnormal_social/conspecific_i | 0.92571862 |
| 109 | MP0000685_abnormal_immune_system | 0.91005099 |
| 110 | MP0004142_abnormal_muscle_tone | 0.90971024 |
| 111 | MP0005666_abnormal_adipose_tissue | 0.89764110 |
| 112 | MP0005621_abnormal_cell_physiology | 0.88534565 |
| 113 | MP0001533_abnormal_skeleton_physiology | 0.86958551 |
| 114 | MP0009840_abnormal_foam_cell | 0.85814171 |
| 115 | MP0000490_abnormal_crypts_of | 0.85169938 |
| 116 | MP0002837_dystrophic_cardiac_calcinosis | 0.84790701 |
| 117 | MP0000003_abnormal_adipose_tissue | 0.84625808 |
| 118 | MP0005165_increased_susceptibility_to | 0.84483681 |
| 119 | MP0001243_abnormal_dermal_layer | 0.83432883 |
| 120 | MP0005385_cardiovascular_system_phenoty | 0.81314882 |
| 121 | MP0001544_abnormal_cardiovascular_syste | 0.81314882 |
| 122 | MP0002396_abnormal_hematopoietic_system | 0.80892175 |
| 123 | MP0005166_decreased_susceptibility_to | 0.80728222 |
| 124 | MP0005386_behavior/neurological_phenoty | 0.80676289 |
| 125 | MP0004924_abnormal_behavior | 0.80676289 |
| 126 | MP0009053_abnormal_anal_canal | 0.80387759 |
| 127 | MP0005397_hematopoietic_system_phenotyp | 0.80291067 |
| 128 | MP0001545_abnormal_hematopoietic_system | 0.80291067 |
| 129 | MP0003631_nervous_system_phenotype | 0.79571636 |
| 130 | MP0008872_abnormal_physiological_respon | 0.79463656 |
| 131 | MP0005595_abnormal_vascular_smooth | 0.78261694 |
| 132 | MP0008770_decreased_survivor_rate | 0.77316710 |
| 133 | MP0005083_abnormal_biliary_tract | 0.77170486 |
| 134 | MP0004808_abnormal_hematopoietic_stem | 0.76866094 |
| 135 | MP0003634_abnormal_glial_cell | 0.75296387 |
| 136 | MP0002882_abnormal_neuron_morphology | 0.75225119 |
| 137 | MP0003453_abnormal_keratinocyte_physiol | 0.75217355 |
| 138 | MP0003186_abnormal_redox_activity | 0.75057928 |
| 139 | MP0002933_joint_inflammation | 0.73940713 |
| 140 | MP0005670_abnormal_white_adipose | 0.73872758 |
| 141 | MP0003300_gastrointestinal_ulcer | 0.73522610 |
| 142 | MP0001879_abnormal_lymphatic_vessel | 0.72634064 |
| 143 | MP0001849_ear_inflammation | 0.72566969 |
| 144 | MP0005000_abnormal_immune_tolerance | 0.72440300 |
| 145 | MP0006036_abnormal_mitochondrial_physio | 0.71741497 |
| 146 | MP0002398_abnormal_bone_marrow | 0.71450751 |
| 147 | MP0001440_abnormal_grooming_behavior | 0.71116531 |
| 148 | MP0003866_abnormal_defecation | 0.70963168 |
| 149 | MP0003448_altered_tumor_morphology | 0.70936122 |
| 150 | MP0000358_abnormal_cell_content/ | 0.70324804 |
| 151 | MP0005620_abnormal_muscle_contractility | 0.68930037 |
| 152 | MP0002796_impaired_skin_barrier | 0.68253534 |
| 153 | MP0002148_abnormal_hypersensitivity_rea | 0.67530549 |
| 154 | MP0002234_abnormal_pharynx_morphology | 0.67434247 |
| 155 | MP0001661_extended_life_span | 0.65770358 |
| 156 | MP0005025_abnormal_response_to | 0.65176252 |
| 157 | MP0002429_abnormal_blood_cell | 0.64733779 |
| 158 | MP0002295_abnormal_pulmonary_circulatio | 0.63647933 |
| 159 | MP0010771_integument_phenotype | 0.63358902 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myokymia (HP:0002411) | 5.40825472 |
| 2 | Visual hallucinations (HP:0002367) | 4.20376436 |
| 3 | Premature rupture of membranes (HP:0001788) | 4.12518171 |
| 4 | Annular pancreas (HP:0001734) | 3.96084238 |
| 5 | Vertebral compression fractures (HP:0002953) | 3.93324665 |
| 6 | Abnormality of the lower motor neuron (HP:0002366) | 3.62046371 |
| 7 | Ventricular fibrillation (HP:0001663) | 3.53951066 |
| 8 | Insomnia (HP:0100785) | 3.50510783 |
| 9 | Hyperacusis (HP:0010780) | 3.36768670 |
| 10 | Spinal canal stenosis (HP:0003416) | 3.20352010 |
| 11 | Distal lower limb amyotrophy (HP:0008944) | 3.06468427 |
| 12 | Ankle clonus (HP:0011448) | 3.05441113 |
| 13 | Distal lower limb muscle weakness (HP:0009053) | 3.00305741 |
| 14 | Protrusio acetabuli (HP:0003179) | 2.99016621 |
| 15 | Depression (HP:0000716) | 2.98034716 |
| 16 | Focal motor seizures (HP:0011153) | 2.97719983 |
| 17 | Cerebral aneurysm (HP:0004944) | 2.93547233 |
| 18 | Spinal rigidity (HP:0003306) | 2.86742819 |
| 19 | Pointed chin (HP:0000307) | 2.86107370 |
| 20 | Supranuclear gaze palsy (HP:0000605) | 2.84963306 |
| 21 | Ankle contracture (HP:0006466) | 2.82356852 |
| 22 | Focal seizures (HP:0007359) | 2.81794898 |
| 23 | Cellulitis (HP:0100658) | 2.81505734 |
| 24 | Fragile skin (HP:0001030) | 2.76931040 |
| 25 | Difficulty climbing stairs (HP:0003551) | 2.71473902 |
| 26 | Distal upper limb amyotrophy (HP:0007149) | 2.71234436 |
| 27 | Upper limb amyotrophy (HP:0009129) | 2.71234436 |
| 28 | Hemiplegia (HP:0002301) | 2.70908479 |
| 29 | Hypercortisolism (HP:0001578) | 2.70765934 |
| 30 | Bundle branch block (HP:0011710) | 2.68367245 |
| 31 | Myotonia (HP:0002486) | 2.66875271 |
| 32 | Achilles tendon contracture (HP:0001771) | 2.66137323 |
| 33 | Growth hormone excess (HP:0000845) | 2.63787194 |
| 34 | Generalized amyotrophy (HP:0003700) | 2.63258226 |
| 35 | Increased connective tissue (HP:0009025) | 2.62753460 |
| 36 | Elbow flexion contracture (HP:0002987) | 2.62077745 |
| 37 | Torticollis (HP:0000473) | 2.59827880 |
| 38 | Papilledema (HP:0001085) | 2.59346152 |
| 39 | Broad metatarsal (HP:0001783) | 2.59297955 |
| 40 | Polygenic inheritance (HP:0010982) | 2.55568263 |
| 41 | Stridor (HP:0010307) | 2.52755044 |
| 42 | Action tremor (HP:0002345) | 2.52163936 |
| 43 | Focal dystonia (HP:0004373) | 2.49137664 |
| 44 | Type 1 muscle fiber predominance (HP:0003803) | 2.47664348 |
| 45 | Large eyes (HP:0001090) | 2.47458301 |
| 46 | Hypertensive crisis (HP:0100735) | 2.42815427 |
| 47 | Mitral regurgitation (HP:0001653) | 2.42348785 |
| 48 | Lower limb amyotrophy (HP:0007210) | 2.40302710 |
| 49 | Craniofacial dystonia (HP:0012179) | 2.40176383 |
| 50 | Ulnar bowing (HP:0003031) | 2.39215278 |
| 51 | Obstructive sleep apnea (HP:0002870) | 2.38074495 |
| 52 | Abnormality of the Achilles tendon (HP:0005109) | 2.38026365 |
| 53 | Testicular atrophy (HP:0000029) | 2.37785637 |
| 54 | Elfin facies (HP:0004428) | 2.37180988 |
| 55 | Joint stiffness (HP:0001387) | 2.33942773 |
| 56 | Anxiety (HP:0000739) | 2.33134154 |
| 57 | Abnormal EKG (HP:0003115) | 2.32713288 |
| 58 | Premature skin wrinkling (HP:0100678) | 2.31436625 |
| 59 | Long toe (HP:0010511) | 2.30212359 |
| 60 | Rapidly progressive (HP:0003678) | 2.28425084 |
| 61 | Biconcave vertebral bodies (HP:0004586) | 2.28211433 |
| 62 | Slender build (HP:0001533) | 2.26619710 |
| 63 | Broad distal phalanx of finger (HP:0009836) | 2.26504914 |
| 64 | Hand muscle atrophy (HP:0009130) | 2.24085811 |
| 65 | Cervical subluxation (HP:0003308) | 2.23485640 |
| 66 | Exercise-induced myalgia (HP:0003738) | 2.22904819 |
| 67 | Ragged-red muscle fibers (HP:0003200) | 2.21836176 |
| 68 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.21783044 |
| 69 | Poor eye contact (HP:0000817) | 2.20331916 |
| 70 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.19889091 |
| 71 | Rough bone trabeculation (HP:0100670) | 2.18548222 |
| 72 | Sudden death (HP:0001699) | 2.15945399 |
| 73 | Wormian bones (HP:0002645) | 2.14653766 |
| 74 | Genu recurvatum (HP:0002816) | 2.14430431 |
| 75 | Striae distensae (HP:0001065) | 2.12561835 |
| 76 | Bowel diverticulosis (HP:0005222) | 2.11737969 |
| 77 | Increased variability in muscle fiber diameter (HP:0003557) | 2.10464548 |
| 78 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.10402222 |
| 79 | Myoglobinuria (HP:0002913) | 2.10392401 |
| 80 | Polycythemia (HP:0001901) | 2.09326401 |
| 81 | Limb-girdle muscle atrophy (HP:0003797) | 2.07859671 |
| 82 | Renal duplication (HP:0000075) | 2.07455119 |
| 83 | Neoplasm of the heart (HP:0100544) | 2.06807344 |
| 84 | Urinary urgency (HP:0000012) | 2.05431773 |
| 85 | Absence seizures (HP:0002121) | 2.03927023 |
| 86 | Abnormality of pain sensation (HP:0010832) | 2.03862460 |
| 87 | Impaired pain sensation (HP:0007328) | 2.03862460 |
| 88 | Diminished motivation (HP:0000745) | 2.03710832 |
| 89 | Pheochromocytoma (HP:0002666) | 2.03651519 |
| 90 | Axonal loss (HP:0003447) | 2.03435820 |
| 91 | Agammaglobulinemia (HP:0004432) | 2.01482478 |
| 92 | Blue sclerae (HP:0000592) | 2.01241596 |
| 93 | Neoplasm of the peripheral nervous system (HP:0100007) | 2.00316287 |
| 94 | Mutism (HP:0002300) | 1.99807341 |
| 95 | Bladder diverticulum (HP:0000015) | 1.99339105 |
| 96 | Heart block (HP:0012722) | 1.99202204 |
| 97 | Abnormal social behavior (HP:0012433) | 1.99103927 |
| 98 | Impaired social interactions (HP:0000735) | 1.99103927 |
| 99 | Unsteady gait (HP:0002317) | 1.97619043 |
| 100 | Menstrual irregularities (HP:0000858) | 1.97420243 |
| 101 | Apathy (HP:0000741) | 1.96714091 |
| 102 | Overriding aorta (HP:0002623) | 1.96028218 |
| 103 | Atrioventricular block (HP:0001678) | 1.95902066 |
| 104 | Hyperthyroidism (HP:0000836) | 1.95337761 |
| 105 | Prolonged QT interval (HP:0001657) | 1.95064010 |
| 106 | Abnormal atrioventricular conduction (HP:0005150) | 1.94748009 |
| 107 | Atrophic scars (HP:0001075) | 1.93667900 |
| 108 | Short nail (HP:0001799) | 1.92148350 |
| 109 | Truncus arteriosus (HP:0001660) | 1.91973857 |
| 110 | J-shaped sella turcica (HP:0002680) | 1.91080224 |
| 111 | Deep palmar crease (HP:0006191) | 1.90506985 |
| 112 | Petechiae (HP:0000967) | 1.90049323 |
| 113 | Abnormal eating behavior (HP:0100738) | 1.89825865 |
| 114 | Radial bowing (HP:0002986) | 1.89792815 |
| 115 | Broad face (HP:0000283) | 1.89608711 |
| 116 | Megalencephaly (HP:0001355) | 1.89603142 |
| 117 | Enlarged penis (HP:0000040) | 1.89399170 |
| 118 | Trismus (HP:0000211) | 1.87447696 |
| 119 | Emphysema (HP:0002097) | 1.87338728 |
| 120 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.86390811 |
| 121 | Delusions (HP:0000746) | 1.84540956 |
| 122 | Long palpebral fissure (HP:0000637) | 1.84311201 |
| 123 | Abnormality of the vocal cords (HP:0008777) | 1.84257548 |
| 124 | Hyperparathyroidism (HP:0000843) | 1.84219545 |
| 125 | Facial edema (HP:0000282) | 1.83842321 |
| 126 | Neuroendocrine neoplasm (HP:0100634) | 1.83562924 |
| 127 | Difficulty running (HP:0009046) | 1.83096174 |
| 128 | Microretrognathia (HP:0000308) | 1.81990586 |
| 129 | Acanthosis nigricans (HP:0000956) | 1.81222583 |
| 130 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.80777593 |
| 131 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.80679824 |
| 132 | Abnormality of alanine metabolism (HP:0010916) | 1.80679824 |
| 133 | Hyperalaninemia (HP:0003348) | 1.80679824 |
| 134 | Myopathic facies (HP:0002058) | 1.80524896 |
| 135 | Bradykinesia (HP:0002067) | 1.79174152 |
| 136 | Gastrointestinal stroma tumor (HP:0100723) | 1.78737309 |
| 137 | Progressive muscle weakness (HP:0003323) | 1.78602281 |
| 138 | Periorbital edema (HP:0100539) | 1.78512285 |
| 139 | Ventricular arrhythmia (HP:0004308) | 1.78236834 |
| 140 | Short clavicles (HP:0000894) | 1.78147094 |
| 141 | Nonimmune hydrops fetalis (HP:0001790) | 1.78002185 |
| 142 | Redundant skin (HP:0001582) | 1.77403966 |
| 143 | Asymmetric septal hypertrophy (HP:0001670) | 1.77164045 |
| 144 | Purpura (HP:0000979) | 1.76718864 |
| 145 | Abnormality of the umbilical cord (HP:0010881) | 1.76666900 |
| 146 | Fatigue (HP:0012378) | 1.76357485 |
| 147 | Renovascular hypertension (HP:0100817) | 1.76237628 |
| 148 | Hypoventilation (HP:0002791) | 1.75009885 |
| 149 | Bulbar palsy (HP:0001283) | 1.74440522 |
| 150 | Palpitations (HP:0001962) | 1.74136670 |
| 151 | Increased muscle lipid content (HP:0009058) | 1.74011690 |
| 152 | Insulin resistance (HP:0000855) | 1.72999143 |
| 153 | Hydroureter (HP:0000072) | 1.72373878 |
| 154 | Dysostosis multiplex (HP:0000943) | 1.72373094 |
| 155 | Atonic seizures (HP:0010819) | 1.72116954 |
| 156 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.71700746 |
| 157 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.71700746 |
| 158 | Stereotypic behavior (HP:0000733) | 1.71559797 |
| 159 | Cerebral inclusion bodies (HP:0100314) | 1.70993673 |
| 160 | Postural instability (HP:0002172) | 1.70427707 |
| 161 | Shallow orbits (HP:0000586) | 1.70286615 |
| 162 | Flat cornea (HP:0007720) | 1.69768948 |
| 163 | Abnormality of dentin (HP:0010299) | 1.67633654 |
| 164 | Prolonged neonatal jaundice (HP:0006579) | 1.65523063 |
| 165 | Disproportionate tall stature (HP:0001519) | 1.65390928 |
| 166 | Abnormality of the tricuspid valve (HP:0001702) | 1.65360742 |
| 167 | Chronic obstructive pulmonary disease (HP:0006510) | 1.64299391 |
| 168 | Obstructive lung disease (HP:0006536) | 1.64299391 |
| 169 | Hypertriglyceridemia (HP:0002155) | 1.63992556 |
| 170 | Muscle stiffness (HP:0003552) | 1.63802826 |
| 171 | Increased intramyocellular lipid droplets (HP:0012240) | 1.63008194 |
| 172 | Aortic aneurysm (HP:0004942) | 1.62938747 |
| 173 | Patellar dislocation (HP:0002999) | 1.62315352 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NME2 | 4.01352844 |
| 2 | TRIB3 | 3.63618771 |
| 3 | MAP3K9 | 2.90916486 |
| 4 | IRAK3 | 2.82886266 |
| 5 | SMG1 | 2.77306465 |
| 6 | PKN2 | 2.63580110 |
| 7 | KSR2 | 2.56057130 |
| 8 | MAPKAPK3 | 2.49407031 |
| 9 | SCYL2 | 2.44210631 |
| 10 | VRK2 | 2.30910277 |
| 11 | PRPF4B | 2.27232287 |
| 12 | EPHA4 | 2.26301836 |
| 13 | KDR | 2.21972161 |
| 14 | TAOK2 | 2.17988352 |
| 15 | CAMKK1 | 2.16707548 |
| 16 | MAP3K11 | 2.16254362 |
| 17 | PAK6 | 2.09637037 |
| 18 | PRKD3 | 2.07658982 |
| 19 | MINK1 | 2.00023070 |
| 20 | NTRK3 | 1.93986609 |
| 21 | TAOK1 | 1.88317433 |
| 22 | LMTK2 | 1.86600404 |
| 23 | CDK19 | 1.85015992 |
| 24 | DAPK1 | 1.82448033 |
| 25 | ARAF | 1.79436794 |
| 26 | EEF2K | 1.77617076 |
| 27 | RIPK1 | 1.70071453 |
| 28 | ERN1 | 1.64439751 |
| 29 | NEK1 | 1.62569576 |
| 30 | ABL2 | 1.59456845 |
| 31 | MAP2K3 | 1.55229098 |
| 32 | EPHA2 | 1.49408764 |
| 33 | DAPK2 | 1.49031691 |
| 34 | MAP3K12 | 1.43096468 |
| 35 | CAMKK2 | 1.42871997 |
| 36 | TESK2 | 1.35946204 |
| 37 | SIK2 | 1.31316461 |
| 38 | NTRK1 | 1.30402858 |
| 39 | BRAF | 1.29956712 |
| 40 | PHKG1 | 1.23366689 |
| 41 | PHKG2 | 1.23366689 |
| 42 | GRK5 | 1.23341743 |
| 43 | LATS2 | 1.22848624 |
| 44 | RAF1 | 1.20284597 |
| 45 | KSR1 | 1.19348134 |
| 46 | TYRO3 | 1.19077819 |
| 47 | PINK1 | 1.15274972 |
| 48 | PDGFRA | 1.09790518 |
| 49 | TIE1 | 1.08335451 |
| 50 | TBK1 | 1.08148159 |
| 51 | MAP3K1 | 1.07814832 |
| 52 | CDK5 | 1.05926706 |
| 53 | LRRK2 | 1.04953402 |
| 54 | MAP3K10 | 1.04821247 |
| 55 | CDK8 | 1.03820147 |
| 56 | CAMK1 | 1.02259345 |
| 57 | STK38 | 0.99918155 |
| 58 | IRAK2 | 0.99226540 |
| 59 | TESK1 | 0.99186669 |
| 60 | LIMK1 | 0.98230544 |
| 61 | TNK2 | 0.97851343 |
| 62 | NTRK2 | 0.96231243 |
| 63 | RET | 0.94859598 |
| 64 | TTN | 0.89389369 |
| 65 | AURKA | 0.89135427 |
| 66 | DAPK3 | 0.88669452 |
| 67 | BCKDK | 0.87108418 |
| 68 | MAP4K1 | 0.85584819 |
| 69 | CDK15 | 0.85402314 |
| 70 | CDK18 | 0.84921344 |
| 71 | UHMK1 | 0.83857326 |
| 72 | ALK | 0.83446501 |
| 73 | CDK11A | 0.82692352 |
| 74 | DDR2 | 0.80890013 |
| 75 | CDK14 | 0.80676220 |
| 76 | FES | 0.80198424 |
| 77 | PRKCH | 0.80005995 |
| 78 | PRKG2 | 0.79028943 |
| 79 | IRAK4 | 0.78718612 |
| 80 | MARK2 | 0.78223637 |
| 81 | PTK2B | 0.77704906 |
| 82 | MAPK11 | 0.75754202 |
| 83 | PAK1 | 0.74902631 |
| 84 | MAP3K13 | 0.74610948 |
| 85 | ICK | 0.73237606 |
| 86 | MAP2K1 | 0.72148116 |
| 87 | MAP2K4 | 0.71832010 |
| 88 | MOS | 0.70770935 |
| 89 | CAMK2G | 0.69990203 |
| 90 | BUB1 | 0.69870224 |
| 91 | ILK | 0.69506870 |
| 92 | MAP3K7 | 0.68306057 |
| 93 | MAP3K3 | 0.66630524 |
| 94 | ZAP70 | 0.64600853 |
| 95 | EPHB2 | 0.64167940 |
| 96 | MYLK | 0.64038080 |
| 97 | RPS6KA2 | 0.61765447 |
| 98 | BMX | 0.61152104 |
| 99 | FLT3 | 0.60577084 |
| 100 | BRSK1 | 0.60478683 |
| 101 | PAK3 | 0.60272758 |
| 102 | MAP3K8 | 0.59431713 |
| 103 | MARK1 | 0.58676781 |
| 104 | MAP3K2 | 0.57385660 |
| 105 | MAPK12 | 0.56031212 |
| 106 | PDK1 | 0.55948282 |
| 107 | PAK2 | 0.55194675 |
| 108 | GRK6 | 0.54795859 |
| 109 | RPS6KC1 | 0.54065821 |
| 110 | RPS6KL1 | 0.54065821 |
| 111 | PIM2 | 0.53203849 |
| 112 | PTK6 | 0.52881725 |
| 113 | MAPK4 | 0.51908555 |
| 114 | CAMK2B | 0.51829075 |
| 115 | CAMK4 | 0.51000727 |
| 116 | SIK3 | 0.50333918 |
| 117 | MST1R | 0.49438472 |
| 118 | PDPK1 | 0.48416413 |
| 119 | PRKCG | 0.47681305 |
| 120 | MAP2K6 | 0.47425562 |
| 121 | PRKCI | 0.47242470 |
| 122 | MAP3K4 | 0.46949410 |
| 123 | MTOR | 0.46245868 |
| 124 | MUSK | 0.46031446 |
| 125 | PAK4 | 0.45725537 |
| 126 | PRKD2 | 0.44763779 |
| 127 | ROCK2 | 0.44489168 |
| 128 | HIPK2 | 0.44333818 |
| 129 | TGFBR2 | 0.44094948 |
| 130 | CDK7 | 0.44018805 |
| 131 | RIPK4 | 0.43687107 |
| 132 | PTK2 | 0.43424756 |
| 133 | MATK | 0.42555325 |
| 134 | RPS6KB2 | 0.40845449 |
| 135 | DMPK | 0.38607276 |
| 136 | SIK1 | 0.37758287 |
| 137 | MAP2K2 | 0.37728074 |
| 138 | PRKD1 | 0.36930770 |
| 139 | RPS6KA6 | 0.36251620 |
| 140 | CDC42BPA | 0.35863416 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.89884611 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.73882197 |
| 3 | Olfactory transduction_Homo sapiens_hsa04740 | 2.59362837 |
| 4 | Ribosome_Homo sapiens_hsa03010 | 2.57229962 |
| 5 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.99395641 |
| 6 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.97380287 |
| 7 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.96191887 |
| 8 | Circadian entrainment_Homo sapiens_hsa04713 | 1.95467118 |
| 9 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.95160324 |
| 10 | Base excision repair_Homo sapiens_hsa03410 | 1.94849456 |
| 11 | Long-term potentiation_Homo sapiens_hsa04720 | 1.90716144 |
| 12 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.90673061 |
| 13 | DNA replication_Homo sapiens_hsa03030 | 1.89823251 |
| 14 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.88503723 |
| 15 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.87339151 |
| 16 | Other glycan degradation_Homo sapiens_hsa00511 | 1.80498665 |
| 17 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.79460029 |
| 18 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.68567385 |
| 19 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.67005694 |
| 20 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.66234439 |
| 21 | Insulin secretion_Homo sapiens_hsa04911 | 1.64316954 |
| 22 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.64241395 |
| 23 | GABAergic synapse_Homo sapiens_hsa04727 | 1.62758729 |
| 24 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.62030148 |
| 25 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.60968874 |
| 26 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.58132165 |
| 27 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.57478814 |
| 28 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.55512392 |
| 29 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.54487525 |
| 30 | Salivary secretion_Homo sapiens_hsa04970 | 1.53875541 |
| 31 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.53840569 |
| 32 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.40426015 |
| 33 | Gap junction_Homo sapiens_hsa04540 | 1.38436029 |
| 34 | Morphine addiction_Homo sapiens_hsa05032 | 1.38193501 |
| 35 | Glioma_Homo sapiens_hsa05214 | 1.34258748 |
| 36 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.33439130 |
| 37 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.30368244 |
| 38 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.28401222 |
| 39 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.26671557 |
| 40 | Cocaine addiction_Homo sapiens_hsa05030 | 1.22588406 |
| 41 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.21161737 |
| 42 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.19103750 |
| 43 | Nicotine addiction_Homo sapiens_hsa05033 | 1.18629494 |
| 44 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.17288763 |
| 45 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.15528503 |
| 46 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.15117828 |
| 47 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.13169843 |
| 48 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.12776210 |
| 49 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.12229849 |
| 50 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.10253779 |
| 51 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.08456673 |
| 52 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.06375730 |
| 53 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.02405740 |
| 54 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.02245763 |
| 55 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.99276568 |
| 56 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.99260815 |
| 57 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.98404509 |
| 58 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.98257290 |
| 59 | Sulfur relay system_Homo sapiens_hsa04122 | 0.96962763 |
| 60 | Endocytosis_Homo sapiens_hsa04144 | 0.95894146 |
| 61 | Renin secretion_Homo sapiens_hsa04924 | 0.95529507 |
| 62 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.95318808 |
| 63 | Apoptosis_Homo sapiens_hsa04210 | 0.94636013 |
| 64 | HTLV-I infection_Homo sapiens_hsa05166 | 0.94340676 |
| 65 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.92255766 |
| 66 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.91820442 |
| 67 | Lysosome_Homo sapiens_hsa04142 | 0.91759739 |
| 68 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.91481281 |
| 69 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.91013694 |
| 70 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.89709649 |
| 71 | Shigellosis_Homo sapiens_hsa05131 | 0.87260543 |
| 72 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.87017675 |
| 73 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.83992042 |
| 74 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.83959121 |
| 75 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.83641093 |
| 76 | Platelet activation_Homo sapiens_hsa04611 | 0.83512107 |
| 77 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.83165282 |
| 78 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.83150436 |
| 79 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.82275567 |
| 80 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.80598424 |
| 81 | Bladder cancer_Homo sapiens_hsa05219 | 0.79881439 |
| 82 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.79717434 |
| 83 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.79714589 |
| 84 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.79448896 |
| 85 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.78480515 |
| 86 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.75198212 |
| 87 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.74577019 |
| 88 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.73356539 |
| 89 | Galactose metabolism_Homo sapiens_hsa00052 | 0.72999790 |
| 90 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.72365425 |
| 91 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.69903893 |
| 92 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.69894659 |
| 93 | Melanogenesis_Homo sapiens_hsa04916 | 0.69620142 |
| 94 | Salmonella infection_Homo sapiens_hsa05132 | 0.69036366 |
| 95 | Thyroid cancer_Homo sapiens_hsa05216 | 0.67356521 |
| 96 | Prion diseases_Homo sapiens_hsa05020 | 0.66159236 |
| 97 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.65935965 |
| 98 | Carbon metabolism_Homo sapiens_hsa01200 | 0.65284162 |
| 99 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.63823577 |
| 100 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.63788035 |
| 101 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.62889101 |
| 102 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.62117295 |
| 103 | Endometrial cancer_Homo sapiens_hsa05213 | 0.61831856 |
| 104 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.61791686 |
| 105 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.61191524 |
| 106 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.60847361 |
| 107 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.60158996 |
| 108 | Colorectal cancer_Homo sapiens_hsa05210 | 0.59962613 |
| 109 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.59929095 |
| 110 | Alzheimers disease_Homo sapiens_hsa05010 | 0.58577566 |
| 111 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.58424897 |
| 112 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.58066889 |
| 113 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.57945885 |
| 114 | Parkinsons disease_Homo sapiens_hsa05012 | 0.57586511 |
| 115 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.57469534 |
| 116 | Taste transduction_Homo sapiens_hsa04742 | 0.57080921 |
| 117 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.56973159 |
| 118 | Amoebiasis_Homo sapiens_hsa05146 | 0.56314129 |
| 119 | Viral myocarditis_Homo sapiens_hsa05416 | 0.55801592 |
| 120 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.55542179 |
| 121 | Alcoholism_Homo sapiens_hsa05034 | 0.55139460 |
| 122 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.54963826 |
| 123 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.54126237 |
| 124 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.54112705 |
| 125 | Leishmaniasis_Homo sapiens_hsa05140 | 0.54036027 |
| 126 | Long-term depression_Homo sapiens_hsa04730 | 0.53296108 |
| 127 | Bile secretion_Homo sapiens_hsa04976 | 0.52718190 |
| 128 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.52286405 |
| 129 | Hepatitis B_Homo sapiens_hsa05161 | 0.51859607 |
| 130 | Focal adhesion_Homo sapiens_hsa04510 | 0.50912469 |
| 131 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.50138677 |
| 132 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.49539899 |
| 133 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.49152557 |
| 134 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.49135549 |
| 135 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.48410595 |
| 136 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.48390655 |
| 137 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.47821632 |
| 138 | Huntingtons disease_Homo sapiens_hsa05016 | 0.47786539 |
| 139 | Melanoma_Homo sapiens_hsa05218 | 0.47740060 |
| 140 | Purine metabolism_Homo sapiens_hsa00230 | 0.47058705 |
| 141 | RNA polymerase_Homo sapiens_hsa03020 | 0.44254656 |
| 142 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.44238061 |
| 143 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.42751377 |
| 144 | Tuberculosis_Homo sapiens_hsa05152 | 0.42474707 |
| 145 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.39864436 |
| 146 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.39464828 |
| 147 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.35710532 |
| 148 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.35085523 |

